Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
A phase II study of laquinimod in Crohn's disease.
Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Function and distribution of three types of rectifying channel in rat spinal root myelinated axons.
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Metabolic features of the cell danger response.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
Laquinimod - New Promising Treatment for Multiple Sclerosis
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Amyloid precursor protein at node of Ranvier modulates nodal formation.
The International Symposium on the Multiple Sclerosis Brain
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Vivitrol dosing and administration
Epstein-Barr virus: an important vaccine target for cancer prevention.
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

Pages